Bookmark and Share

$TGODF Growing Markets Incite Cannabis Companies to Extend Their Roots

POINT ROBERTS, Wash. and DELTA, British Columbia, Feb. 12, 2019 —, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing demand for diversification, whether through e-commerce infrastructure or a proper CBD catalogue, as the cannabis industry keeps growing.

In a recent report from Brightfield Group: “The CBD market is projected to have reached $591 million in 2018, and the pet CBD market expected to have a CAGR or 195% from 2018 to 2022, outpacing the general CBD market’s CAGR of 147% for the same period. The beauty and skincare topicals are expected to have a whopping five-year CAGR of 214%, and drinks are expected to be a huge CBD growth area, projected to jump from a $12 million market in 2018 to a $200 million-plus market in 2019 with a compound annual growth rate (CAGR) of 242% through 2022.”

Growth in the CBD market as well as online e-commerce growth is changing the game, forcing companies to adapt and diversify in order to ride this growing green wave.

MassRoots, Inc. (OTC: MSRT), one of the leading technology platforms for the regulated cannabis industry is an example of one such company looking to further its reach in these expanding markets.

Powered by more than one million registered users, the Company’s mobile apps empower consumers to make educated cannabis purchasing decisions through community-driven reviews.

The company announced recently that it has entered into a definitive agreement to acquire COWA Sciences, Inc., a supply-chain as a service company, for common-stock consideration valued at approximately $8 million.

News: “MassRoots’ management team has been observing COWA Sciences and their growth trajectory for several years and are impressed with the book of business they’ve built with minimal outside capital investment,” stated Mr. Isaac Dietrich, MassRoots’ Chief Executive Officer. “This acquisition will be immediately accretive and allow us to better diversify ourselves in the rapidly emerging cannabis industry. Going forward, MassRoots is confident that the addition of COWA Sciences will increase overall revenues, expand our market presence and generate positive cash-flows from operations.”

MassRoots, Inc. also made another recent announcement on signing an agreement with New Age Brands subsidiary, We are Kured, LLC to serve as a leading online retailer of the Company’s #1 best-selling CBD Pen.

We Are Kured, LLC’s Vaporizer Pen will be the first CBD product to be sold directly through MassRoots’ impressive online platform and social media pages.

MassRoots is following in the footsteps of one of the world’s largest cannabis companies, Canopy Growth Corp. (NYSE: CGC) (TSX:WEED.TO), who recently outlined their CBD and Hemp plans moving forward.

In their outline Bruce Linton, Chairman & Co-CEO, Canopy Growth commented, “Canopy has been preparing for and investing in this opportunity for several years now, through strategic acquisitions, infrastructure expansion, and extensive internal research and development. With the door now open, we are moving fast to bring our considerable resources to establish the same market leadership position internationally that we have earned in the Canadian cannabis market. Canopy has a strong supply of CBD, a significant channel presence, the IP to drive the CBD industry forward to the benefit of consumers, and the balance sheet needed to act now.”

Other companies are looking to expand their online performance as The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (TGODF) and HelloMD, a leading online cannabis healthcare company, announced their partnership last December to streamline TGOD’s medical cannabis onboarding experience in which TGOD will begin selling its premium, certified-organic cannabis to medical patients in late January. With this in mind, TGOD also upgraded its online experience to include patient portals, consumer education centers and an entirely redesigned investor section.

Australis Capital Inc. (CSE:AUSA) (OTC:AUSCF) also announced their interest in the CBD space with their recent investment of $3,000,000 USD in Folium Biosciences, the largest vertically integrated producer, manufacturer and distributor of hemp derived phytocannabinoids in the United States. Folium also owns and operates the largest phytocannabinoid extraction and purification facility in the United States, with plans for a new pharmaceutical division and the completion of their Canadian facility in 2019.

Just as tree roots search for alternate sources of water, cannabis companies must seek out alternate sources of revenue to compete in this ever changing landscape.

Investor Ideas has created a stock directory for investors following the sector; publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks.

About – News that Inspires Big Investing Ideas

Follow our Cannabis Social Media

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Disclosure: this news article featuring MSRT is a paid for news release on – third party , Learn more about costs and our services

Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.
Privacy policy:


Tuesday, February 12th, 2019 Uncategorized